Quality-by-Design II: Application of Quantitative Risk Analysis to the Formulation of Ciprofloxacin Tablets
H Gregg Claycamp1,2, Ravikanth Kona3, Raafat Fahmy2
1Office of Compliance, FDA Center for Drug Evaluation and Research, Silver Spring, MD, USA.
This study introduces a quantitative risk assessment strategy using Bayesian Monte Carlo simulation. It effectively defines design space boundaries by integrating qualitative and quantitative risk analysis for robust product development.
Area of Science:
- Pharmaceutical Science
- Risk Management
- Statistical Modeling
Background:
- Qualitative risk assessment is standard for initial design space boundary determination.
- Quantitative risk assessment is crucial for fully characterizing design space boundaries by calculating failure probabilities.
- Previous work utilized Failure Mode and Effects Analysis (FMEA) and Plackett-Burman designs to identify critical quality attributes.
Purpose of the Study:
- To demonstrate a simplified strategy for design space definition.
- To utilize a simplified Bayesian Monte Carlo simulation for quantitative risk assessment.
- To integrate qualitative and quantitative risk assessment for robust design space definition.
Main Methods:
- Employed a simplified Bayesian Monte Carlo simulation.
- Built upon prior qualitative risk assessment (FMEA) and design of experiments.
- Sequentially applied qualitative and quantitative risk assessment methods.
Main Results:
- The sequential approach effectively focused design of experiments on critical parameters.
- Identified a reduced set of critical material and process parameters for a robust design space.
- Enabled calculation of risk associated with each parameter under limited experimentation.
Conclusions:
- The sequential use of qualitative and quantitative risk assessments is a viable strategy for defining robust design spaces.
- This method aids in managing risk to acceptable levels by allocating resources effectively.
- Facilitates a comprehensive understanding of design space boundaries with limited laboratory data.
More Related Videos
Related Concept Videos
Clinically Relevant Drug Product Specifications: Methods of Establishment
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules
Drug Dissolution: Requirements and Profile Comparison
Inhibitors of Bacterial DNA Synthesis
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...


